[A case of pleuritis caused by strongyloides in a carrier of T-cell lymphoma virus type I (HTLV-I)].
A 73-year-old woman was admitted to our hospital complaining of dyspnea, fever and general edema. Chest roentgenogram showed bilateral pleural effusion and cardiomegaly. Cardiovascular examination demonstrated atrial tachycardia and left ventricle dysfunction, suggesting congestive heart failure. She was sero-positive for human T-cell lymphoma virus I (HTLV-I). The dyspnea and general edema improved after therapy for heart failure. Because the pleural effusion persisted after therapy, thoracentesis was performed. The pleural effusion was an exudate, and Strongyloides sterocoralis was detected by microscopy. Two courses of thiabendazole (1,500 mg/day, 3 days) were given orally. After this therapy, the pleural effusion improved markedly. This case suggests that Strongyloides stercoralis may be a causative agent of pleuritis in HTLV-I endemic areas.
Oya
H
H
Division of Respiratory Diseases, Akune City General Hospital, Kagoshima, Japan.
Mori
S
S
Tsuchihashi
H
H
Kurono
A
A
Mizoguchi
A
A
Kawabata
M
M
Arimura
K
K
Osame
M
M
D000368:Aged; D000818:Animals; D000969:Antinematodal Agents / Q000627:therapeutic use; D002353:Carrier State; D005260:Female; D015490:HTLV-I Infections / Q000150:complications*; D006801:Humans; D009894:Opportunistic Infections / Q000150:complications* / Q000188:drug therapy; D010998:Pleurisy / Q000188:drug therapy / Q000469:parasitology*; D017171:Strongyloides stercoralis / Q000302:isolation & purification*; D013322:Strongyloidiasis; D013827:Thiabendazole / Q000627:therapeutic use
D000969:Antinematodal Agents; D013827:Thiabendazole